Prospective Descriptive Study of Injuries Associated to Anterior Shoulder Dislocations in Patients Over 40 Years

Recruiting now

Conditions studied: Anterior Glenohumeral Dislocations

In brief

The glenohumeral joint has the highest rate of dislocation of the whole body, due to its high mobility and the special characteristics of its anatomy. It is estimated that every year between 1-2% of the population will suffer from glenohumeral dislocation. The vast majority of studies are based on young patients under the age of 40, given that at this age they have the higher incidence and at the same time, they have higher redislocation index. However, the investigators are in front of a more active population with a longer life expectancy. That is why the cases of anterior glenohumeral dislocations are increasing in people older than 40 years. Given that most studies focus on younger patients, the investigators lack knowledge about which injuries are associated with dislocation at this age and whether these influence its clinical evolution.

Key facts

Study ID

NCT05898243

Run by

Corporacion Parc Tauli

People needed

120

Starts

2023-06-01

Expected to finish

2028-05-31

Last updated by the study team

2024-02-07

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• More than 40 years old
• First episode of traumatic anterior gelnohumeral dislocation seen in Rx
• Acceptance to be checked over 2 years
• Acceptance to be submitted to TAC, NMR, EMG and Bilateral Ultrasound

You may not qualify if…

• Previous fractures in this extremity
• Previous neurovascular lesions in this extremity
• Other associated lesions
• Cognitive alterations or dementia which prevent completing the protocols. Patients with <14 points in Mini-mental test.

Where it is running

• Hospital Parc Taulí — Sabadell, Barcelona, Spain (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.